triazoles has been researched along with albaconazole in 25 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (8.00) | 18.2507 |
2000's | 17 (68.00) | 29.6817 |
2010's | 6 (24.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Algueró, M; Bartroli, J; Boncompte, E; Conte, L; Forn, J; García-Rafanell, J; Merlos, M; Ramis, J; Turmo, E; Vericat, ML | 1 |
Cuenca-Estrella, M; Monzón, A; Ramos, G; Rodríguez-Tudela, JL | 1 |
Bartrolí, J; Lira, R; Urbina, JA; Visbal, G | 1 |
Carrillo, AJ; Guarro, J | 1 |
Capilla, J; Guarro, J; Ortoneda, M; Pastor, FJ | 1 |
Urbina, JA | 1 |
Capilla, J; Fernández, B; Guarro, J; Mayayo, E; Ortoneda, M; Pastor, FJ; Yustes, C | 1 |
del Palacio, A; Garau, M; Pereiro, M | 1 |
Bartroli, J; Benjamin, DK; Boyce, M; Miller, JL; Perfect, JR; Schell, WA; Toffaletti, DL; Wills, EA | 1 |
Capilla, J; Guarro, J; Javier Pastor, F; Ortoneda, M; Pujol, I | 1 |
Belloc, J; Parella, T; Sánchez-Ferrando, F | 1 |
Fernández-Torres, B; Guarro, J; Lazéra, Mdos S; Trilles, L; Wanke, B | 1 |
Afonso, LC; Bahia, MT; Chiari, E; de Lana, M; Guedes, PM; Machado-Coelho, GL; Tafuri, WL; Urbina, JA; Veloso, VM | 1 |
Baró-Tomás, T; Jiménez-Cabello, T; Morera-López, Y; Torres-Rodríguez, JM | 1 |
Alves, SH; Azevedo, AC; Boff, E; Da Matta, DA; Guarro, J; Loreto, ES; Santurio, JM | 1 |
Cano, J; Gené, J; Gilgado, F; Guarro, J; Serena, C | 1 |
Denning, DW; Pasqualotto, AC | 1 |
Arechavala, AI; Bianchi, MH; Negroni, R; Robles, AM; Santiso, G | 1 |
Elizondo, M; Garza-González, E; González, GM; González, JG; Robledo, E | 1 |
Goldani, LZ; Pasqualotto, AC; Thiele, KO | 1 |
Sheng, CQ; Wang, SZ; Zhang, WN | 1 |
Türel, O | 1 |
Malahias, S; Raterink, K; Sigurgeirsson, B; van Rossem, K | 1 |
Dubey, AK; Singla, RK; Srivastava, V | 1 |
Karasawa, T; Kumagai, N; Oriez, R; Shibasaki, M | 1 |
6 review(s) available for triazoles and albaconazole
Article | Year |
---|---|
Specific treatment of Chagas disease: current status and new developments.
Topics: Chagas Disease; Cysteine Proteinase Inhibitors; Humans; Quinazolines; Triazoles | 2001 |
New and emerging treatments for fungal infections.
Topics: Animals; Antifungal Agents; Drug Resistance, Fungal; Humans; Mycoses; Quinazolines; Stereoisomerism; Triazoles | 2008 |
Novel triazole antifungal drugs: focus on isavuconazole, ravuconazole and albaconazole.
Topics: Animals; Antifungal Agents; Clinical Trials as Topic; Drug Resistance, Fungal; Fungi; Humans; Microbial Sensitivity Tests; Mycoses; Nitriles; Pyridines; Quinazolines; Thiazoles; Triazoles | 2010 |
[Recent advances in the study of new antifungal lead compounds].
Topics: Antifungal Agents; Fungi; Heterocyclic Compounds; Humans; Lipopeptides; Molecular Structure; Mycoses; Nitriles; Plant Extracts; Plants, Medicinal; Pyridines; Quinazolines; Quinones; Structure-Activity Relationship; Thiazoles; Triazoles | 2010 |
Newer antifungal agents.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis, Invasive; Child; Clinical Trials as Topic; Half-Life; Humans; Lipopeptides; Nitriles; Pyridines; Quinazolines; Thiazoles; Triazoles | 2011 |
Emerging Virulence, Drug Resistance and Future Anti-fungal Drugs for Candida Pathogens.
Topics: Amidines; Antifungal Agents; Candida; Drug Resistance, Fungal; Glycosides; Microbial Sensitivity Tests; Pyridines; Quinazolines; Tetrazoles; Triazoles; Triterpenes; Virulence | 2018 |
1 trial(s) available for triazoles and albaconazole
Article | Year |
---|---|
A phase II, randomized, double-blind, placebo-controlled, parallel group, dose-ranging study to investigate the efficacy and safety of 4 dose regimens of oral albaconazole in patients with distal subungual onychomycosis.
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Double-Blind Method; Female; Foot Dermatoses; Humans; Male; Middle Aged; Onychomycosis; Quinazolines; Time Factors; Treatment Outcome; Triazoles; Young Adult | 2013 |
18 other study(ies) available for triazoles and albaconazole
Article | Year |
---|---|
New azole antifungals. 3. Synthesis and antifungal activity of 3-substituted-4(3H)-quinazolinones.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candidiasis; Colony Count, Microbial; Fungi; Male; Mice; Molecular Conformation; Quinazolines; Rabbits; Rats; Rats, Sprague-Dawley; Stereoisomerism; Structure-Activity Relationship; Triazoles | 1998 |
In-vitro comparative activity of UR-9825, itraconazole and fluconazole against clinical isolates of Candida spp.
Topics: Antifungal Agents; Candida; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Quinazolines; Triazoles | 1999 |
In vitro antiproliferative effects and mechanism of action of the new triazole derivative UR-9825 against the protozoan parasite Trypanosoma (Schizotrypanum) cruzi.
Topics: Animals; Antiprotozoal Agents; Cell Division; Drug Evaluation, Preclinical; Phospholipids; Quinazolines; Structure-Activity Relationship; Triazoles; Trypanosoma cruzi | 2000 |
In vitro activities of four novel triazoles against Scedosporium spp.
Topics: Antifungal Agents; Humans; Microbial Sensitivity Tests; Pyrimidines; Quinazolines; Scedosporium; Thiazoles; Triazoles; Voriconazole | 2001 |
In vitro antifungal activities of the new triazole UR-9825 against clinically important filamentous fungi.
Topics: Antifungal Agents; Aspergillus fumigatus; Fusarium; Humans; Microbial Sensitivity Tests; Paecilomyces; Quinazolines; Triazoles | 2001 |
Efficacy of albaconazole (UR-9825) in treatment of disseminated Scedosporium prolificans infection in rabbits.
Topics: Animals; Antifungal Agents; Male; Mycetoma; Quinazolines; Rabbits; Scedosporium; Survival Analysis; Triazoles | 2003 |
In vitro susceptibilities of Malassezia species to a new triazole, albaconazole (UR-9825), and other antifungal compounds.
Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Flucytosine; In Vitro Techniques; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Pyrimidines; Quinazolines; Triazoles; Voriconazole | 2003 |
In vitro and in vivo efficacies of the new triazole albaconazole against Cryptococcus neoformans.
Topics: Animals; Antifungal Agents; Colony Count, Microbial; Cryptococcus neoformans; Fluconazole; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Quinazolines; Rabbits; Survival Analysis; Triazoles | 2004 |
In vitro interactions of licensed and novel antifungal drugs against Fusarium spp.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Drug Resistance, Fungal; Fusarium; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Quinazolines; Sensitivity and Specificity; Terbinafine; Thiazoles; Triazoles; Voriconazole | 2004 |
Measurement of the sign and the magnitude of heteronuclear coupling constants from spin-state-edited J-cross-polarization NMR experiments.
Topics: Carbon; Data Interpretation, Statistical; Magnetic Resonance Spectroscopy; Menthol; Molecular Conformation; Nuclear Magnetic Resonance, Biomolecular; Protons; Quinazolines; Sensitivity and Specificity; Spin Labels; Triazoles | 2004 |
In vitro antifungal susceptibility of Cryptococcus gattii.
Topics: Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Humans; Microbial Sensitivity Tests; Quinazolines; Thiazoles; Triazoles | 2004 |
Activity of the new triazole derivative albaconazole against Trypanosoma (Schizotrypanum) cruzi in dog hosts.
Topics: Animals; Chagas Disease; Dogs; Enzyme-Linked Immunosorbent Assay; Immunoglobulin G; Monocytes; Nifurtimox; Nitroimidazoles; Quinazolines; Reverse Transcriptase Polymerase Chain Reaction; Triazoles; Trypanocidal Agents; Trypanosoma cruzi | 2004 |
Cryptococcus gattii: in vitro susceptibility to the new antifungal albaconazole versus fluconazole and voriconazole.
Topics: Animals; Antifungal Agents; Cryptococcosis; Cryptococcus; Fluconazole; Humans; Microbial Sensitivity Tests; Pyrimidines; Quinazolines; Soil Microbiology; Triazoles; Voriconazole | 2005 |
In vitro activities of new and conventional antimycotics against fluconazole-susceptible and non-susceptible Brazilian Candida spp. isolates.
Topics: Antifungal Agents; Brazil; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Humans; Microbial Sensitivity Tests; Quinazolines; Thiazoles; Triazoles | 2006 |
Antifungal susceptibilities of the species of the Pseudallescheria boydii complex.
Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Naphthalenes; Peptides, Cyclic; Pseudallescheria; Pyrimidines; Quality Control; Quinazolines; Scedosporium; Terbinafine; Thiazoles; Triazoles; Voriconazole | 2006 |
[Identification and susceptibility against fluconazole and albaconazole of 100 yeasts' strains isolated from vaginal discharge].
Topics: Adult; Antifungal Agents; Body Fluids; Candida; Candida albicans; Candida glabrata; Candidiasis, Vulvovaginal; Drug Resistance, Fungal; Female; Fluconazole; Humans; Microbial Sensitivity Tests; Middle Aged; Quinazolines; Triazoles; Trichosporon; Vagina | 2007 |
Efficacy of albaconazole against Candida albicans in a vaginitis model.
Topics: Administration, Oral; Animals; Antifungal Agents; Candida albicans; Female; Fluconazole; Mice; Mice, Inbred BALB C; Quinazolines; Triazoles; Vaginitis | 2009 |
anti-Selective Catalytic Asymmetric Nitroaldol Reaction of α-Keto Esters: Intriguing Solvent Effect, Flow Reaction, and Synthesis of Active Pharmaceutical Ingredients.
Topics: Alcohols; Catalysis; Esters; Furans; Ketones; Neodymium; Nitro Compounds; Quinazolines; Sodium; Solvents; Stereoisomerism; Triazoles | 2018 |